Phase 3 trials for acne treatment show promising resultsThe tetracycline-derived antibiotic sarecycline from Allergan plc and Paratek Pharmaceuticals Inc. for the treatment of moderate-to-severe acne has been found effective and safe, according to the results of two phase 3 trials.
June Clinical Considerations for NPs, PAsThis month, our clinical considerations include articles on the role of the microbe in acne, data around a topical agent to treat tinea pedis, and insights on sebum interacts with airborne pollution.
Microbe imbalance fuels acneThe difference between acne and healthy skin is largely dependent on the balance of the skin microbiota, according to study results.
Laser treatments found safe, effectiveA new study finds that use of dual laser therapy alone in skin types V and VI achieves excellent results with an exceptional side-effect profile.
Office-based alternative to in-home oral and topical regimenApplication of a topical photoparticle immediately before non-ablative 810 nm diode laser treatment for acne resulted in a statistically significant reduction from baseline in inflammatory acne counts on the back, according to a small feasibility study.
Hormonal therapies effective for acneHormonal therapies are an effective strategy to improve acne in women but some of these treatments, including birth control pills, are not commonly prescribed.
Isotretinoin still the best drug for acne
Isotretinoin still the best drug for acneAs part of its updated guidelines for the treatment of acne published early last year, the American Academy of Dermatology included new recommendations for the use of oral isotretinoin.